This morning, Moderna said it would ask US and European regulators to allow emergency use of its COVID-19 vaccine as new study results confirm the vaccine offers strong protection against the coronavirus. Moderna said it will ask the US FDA for emergency use authorization after completing its Phase 3 trial which found the vaccine to be almost 95% effective against COVID. Katie Couric spoke to Dr. Stephen Hoge, doctor, scientist, and president of Moderna, about the COVID-19 vaccine the company is working on.

Subscribe to my channel: [ Ссылка ]
Follow me on Instagram: [ Ссылка ]
Subscribe to my podcast: ApplePodcasts.com/KatieCouric
Follow me on Facebook: [ Ссылка ]
Follow me on Twitter: [ Ссылка ]

свернуть